MabGenesis

MabGenesis is a pioneering biotechnology company focused on expanding the druggable space through its innovative antibody discovery platform. The company specializes in developing therapeutic antibodies for animal health and oncology, targeting previously undruggable gene families and membrane proteins. MabGenesis operates in the biotechnology and pharmaceutical markets, serving clients that include pharmaceutical companies, research institutions, and veterinary organizations. The business model revolves around research collaborations, licensing agreements, and milestone payments, generating revenue through partnerships and the commercialization of its proprietary antibody technologies.

Keywords: antibody discovery, druggable space, animal health, oncology, biotechnology, pharmaceutical, therapeutic antibodies, gene families, membrane proteins, research collaborations.